玻璃体视网膜术后高眼压和其他不良反应的发生率

作     者：Anderson N.G. FinemanM.S. BrownG.C. 潘佳鸿 

作者机构：Southeastern Retina Associates 1124 East Weisgarber Road Knoxville TN 37909 United States Dr. 

出 版 物：《世界核心医学期刊文摘（眼科学分册）》 (Digest of the World Core Medical Journals:Ophthalmology)

年 卷 期：2006年第2卷第5期

页      面：52-53页

学科分类：1007[医学-药学(可授医学、理学学位)] 1002[医学-临床医学] 100212[医学-眼科学] 10[医学] 

主　　题：玻璃体视网膜手术 全身不良反应 术后高眼压 发生率 全身性不良反应 住院患者 缓解疼痛 血糖升高 巩膜扣带术 玻璃体切除 

摘      要：PURPOSE: To determine the incidence of significant postoperative intraocular pressure(IOP) elevation and other adverse medical events during the first postoperative day in patients undergoing inpatient vitreoretinal surgery. Design: Noncomparative interventional case series. Participants: Two hundred two consecutive patients were admitted prospectively as inpatients after vitreoretinal surgery (vitrectomy and/or scleral buckling). Methods: Intraocular pressure was measured preoperatively, 5 to 12 hours postoperatively, and on postoperative day 1. Additionally, pain, nausea, and serious systemic adverse events were monitored. Results: Seventeen patients (8.4%)-had a 5-to 12-hour IOP measurement above 29 mmHg. Thirty patients (14.8%) had a postoperative day 1 IOP measurement above 29 mmHg. Three patients (1.5%) required a parenteral narcotic to achieve adequate analgesia. Nine patients (4.5%)-utilized a parenteral antiemetic for nausea control. Six patients (3.0%) had a hyperglycemicevent. No serious systemic adverse events occurred in the early postoperative period. Conclusions: The incidence of a significant IOP spike or systemic adverse events in the early postoperative period in patients undergoing vitreoretinal surgery is low.